X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23752) 23752
Book / eBook (26) 26
Book Chapter (21) 21
Dissertation (5) 5
Web Resource (5) 5
Magazine Article (4) 4
Streaming Video (4) 4
Conference Proceeding (2) 2
Reference (2) 2
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (20691) 20691
neuroprotective agents - pharmacology (15780) 15780
rats (11446) 11446
neurosciences (10388) 10388
male (10152) 10152
humans (7809) 7809
neuroprotective agents - therapeutic use (6828) 6828
neuroprotection (6491) 6491
mice (6065) 6065
neurons - drug effects (5510) 5510
oxidative stress (5457) 5457
rats, sprague-dawley (5288) 5288
disease models, animal (5208) 5208
brain (4688) 4688
apoptosis (4349) 4349
pharmacology & pharmacy (3973) 3973
neurons - metabolism (3850) 3850
neurons (3680) 3680
apoptosis - drug effects (3435) 3435
rats, wistar (3419) 3419
cells, cultured (3391) 3391
neurology (3366) 3366
biochemistry & molecular biology (3339) 3339
female (3087) 3087
brain - drug effects (2983) 2983
oxidative stress - drug effects (2942) 2942
dose-response relationship, drug (2859) 2859
brain - metabolism (2831) 2831
cell survival - drug effects (2682) 2682
ischemia (2563) 2563
neuroprotective agents - administration & dosage (2507) 2507
analysis (2482) 2482
alzheimers-disease (2364) 2364
stroke (2221) 2221
expression (2125) 2125
neuroprotective agents - metabolism (2125) 2125
neurons - pathology (2096) 2096
mice, inbred c57bl (2084) 2084
hippocampus - drug effects (2060) 2060
cell biology (2043) 2043
alzheimer's disease (2021) 2021
activation (1985) 1985
clinical neurology (1973) 1973
signal transduction - drug effects (1893) 1893
inflammation (1888) 1888
parkinson's disease (1805) 1805
brain - pathology (1743) 1743
time factors (1724) 1724
antioxidants (1721) 1721
reactive oxygen species - metabolism (1715) 1715
neurotoxicity (1670) 1670
neurodegeneration (1650) 1650
cell death - drug effects (1630) 1630
hippocampus - metabolism (1629) 1629
cell-death (1626) 1626
antioxidants - pharmacology (1608) 1608
biomedicine (1600) 1600
in-vitro (1580) 1580
brain ischemia - drug therapy (1565) 1565
neuroprotective agents - chemistry (1551) 1551
rodents (1536) 1536
glutamate (1532) 1532
neuroprotective agents (1492) 1492
parkinsons-disease (1392) 1392
rat (1379) 1379
immunohistochemistry (1355) 1355
pc12 cells (1346) 1346
brain ischemia - metabolism (1330) 1330
inhibition (1295) 1295
hippocampus (1294) 1294
proteins (1284) 1284
neurodegenerative diseases (1257) 1257
cell line, tumor (1235) 1235
neurons - cytology (1209) 1209
injury (1204) 1204
cell death (1197) 1197
brain ischemia - pathology (1165) 1165
cerebral-ischemia (1163) 1163
cells (1150) 1150
cell line (1149) 1149
in-vivo (1145) 1145
alzheimer disease - drug therapy (1143) 1143
endocrinology & metabolism (1139) 1139
research (1122) 1122
chemistry, medicinal (1119) 1119
animals, newborn (1108) 1108
injuries (1087) 1087
phosphorylation (1073) 1073
mechanisms (1061) 1061
mitochondria - drug effects (1056) 1056
focal cerebral-ischemia (1038) 1038
mitochondria (1023) 1023
hippocampus - pathology (1019) 1019
health aspects (1016) 1016
nervous system diseases (1012) 1012
cerebral ischemia (1010) 1010
damage (1009) 1009
physiological aspects (1008) 1008
death (996) 996
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (23524) 23524
Chinese (359) 359
Japanese (225) 225
Russian (167) 167
German (60) 60
Spanish (38) 38
French (32) 32
Polish (25) 25
Hungarian (22) 22
Ukrainian (12) 12
Portuguese (10) 10
Dutch (3) 3
Czech (2) 2
Finnish (2) 2
Romanian (2) 2
Bulgarian (1) 1
Catalan (1) 1
Danish (1) 1
Italian (1) 1
Korean (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current medicinal chemistry, ISSN 0929-8673, 03/2016, Volume 23, Issue 8, pp. 774 - 791
Morin is a natural polyphenol, originally isolated from members of the Moraceae family that can be extracted from leaves, fruits, stems and branches of... 
Natural drug | Polyphenol | Morin | Anti-oxidant | Anti-diabetic | Anti-inflammatory | Flavonoid | OXIDATIVE STRESS | CHEMISTRY, MEDICINAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | anti-oxidant | polyphenol | PSIDIUM-GUAJAVA | ANTIOXIDANT ACTIVITY RELATIONSHIPS | P-GLYCOPROTEIN | IN-VITRO | INDUCED DIABETIC-RATS | anti-inflammatory | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | flavonoid | anti-diabetic | NATURALLY-OCCURRING FLAVONOIDS | HUMAN MAST-CELLS | natural drug | QUANTITATIVE STRUCTURE | Antihypertensive Agents - pharmacology | Antioxidants - chemistry | Hypoglycemic Agents - metabolism | Antioxidants - metabolism | Humans | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Biological Products - pharmacology | Antihypertensive Agents - metabolism | Neuroprotective Agents - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Antineoplastic Agents - metabolism | Neuroprotective Agents - pharmacology | Anti-Bacterial Agents - chemistry | Antineoplastic Agents - pharmacology | Flavonoids - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Neuroprotective Agents - chemistry | Anti-Bacterial Agents - metabolism | Hypoglycemic Agents - chemistry | Antioxidants - pharmacology | Antineoplastic Agents - chemistry | Hypoglycemic Agents - pharmacology | Antihypertensive Agents - chemistry | Biological Products - chemistry | Animals | Flavonoids - metabolism | Biological Products - metabolism | Anti-Bacterial Agents - pharmacology | Flavonoids - chemistry
Journal Article
Food and chemical toxicology, ISSN 0278-6915, 2015, Volume 83, pp. 111 - 124
The concept of using phytochemicals has ushered in a new revolution in pharmaceuticals. Naturally occurring polyphenols (like curcumin, morin, resveratrol,... 
Neurodegenerative disease | Curcumin | Inflammation | Diabetes | Antioxidant | Cancer | OXIDATIVE STRESS | WINGLESS SIGNALING PATHWAY | FOOD SCIENCE & TECHNOLOGY | DOWN-REGULATION | CELL-CYCLE ARREST | ENDOPLASMIC-RETICULUM STRESS | FORKHEAD TRANSCRIPTION FACTORS | ARJUNOLIC ACID | IN-VITRO | RETRACTED ARTICLE. SEE | TOXICOLOGY | NF-KAPPA-B | Neoplasms - metabolism | Neuroprotective Agents - therapeutic use | Arthritis - metabolism | Hypoglycemic Agents - metabolism | Antioxidants - metabolism | Cardiovascular Diseases - prevention & control | Humans | Neurodegenerative Diseases - prevention & control | Neoplasms - prevention & control | Curcumin - metabolism | Neuroprotective Agents - metabolism | Antineoplastic Agents, Phytogenic - metabolism | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Dietary Supplements - adverse effects | Neuroprotective Agents - adverse effects | Antineoplastic Agents, Phytogenic - therapeutic use | Arthritis - prevention & control | Antineoplastic Agents, Phytogenic - adverse effects | Diabetes Complications - prevention & control | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - metabolism | Curcumin - therapeutic use | Diabetes Complications - metabolism | Curcumin - adverse effects | Neurodegenerative Diseases - metabolism | Antioxidants - therapeutic use | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Antioxidants - adverse effects | Hypoglycemic Agents - adverse effects | Antioxidants | Polyphenols | Nervous system diseases | Arthritis | Resveratrol | Index Medicus
Journal Article
Journal of controlled release, ISSN 0168-3659, 2015, Volume 207, pp. 18 - 30
Exosomes are naturally occurring nanosized vesicles that have attracted considerable attention as drug delivery vehicles in the past few years. Exosomes are... 
Oxidative stress | Neuroinflammation | Parkinson's disease | Catalase | Exosomes | Blood–brain barrier | Blood-brain barrier | ALZHEIMERS-DISEASE | REPEATED INJECTIONS | MACROPHAGE DELIVERY | MEDIATED TRANSFER | BLOOD-BRAIN-BARRIER | BIOLOGICAL BARRIERS | CHEMISTRY, MULTIDISCIPLINARY | IN-VITRO | PEGYLATED LIPOSOMES | PHARMACOLOGY & PHARMACY | SUPEROXIDE-DISMUTASE | Antioxidants - chemistry | Antioxidants - metabolism | Oxidopamine | Anti-Inflammatory Agents - metabolism | PC12 Cells | Neuroprotective Agents - metabolism | Drug Carriers | Brain - metabolism | Nanoparticles | Parkinsonian Disorders - metabolism | Parkinsonian Disorders - drug therapy | Antiparkinson Agents - chemistry | Anti-Inflammatory Agents - administration & dosage | Female | Neurons - metabolism | Neuroprotective Agents - administration & dosage | Nanomedicine | Disease Models, Animal | Neuroprotective Agents - chemistry | Mice, Inbred C57BL | Solubility | Rats | Technology, Pharmaceutical - methods | Parkinsonian Disorders - chemically induced | Administration, Intranasal | Chemistry, Pharmaceutical | Brain - drug effects | Catalase - metabolism | Catalase - administration & dosage | Animals | Anti-Inflammatory Agents - chemistry | Antioxidants - administration & dosage | RAW 264.7 Cells | Antiparkinson Agents - administration & dosage | Mice | Kinetics | Oxidative Stress - drug effects | Antiparkinson Agents - metabolism | Catalase - chemistry | Drugs | Drug delivery systems | Proteases | Analysis | Antiparkinsonian agents | Vehicles | blood-brain barrier | neuroinflammation | exosomes | catalase | oxidative stress | Parkinson’s disease
Journal Article
Pharmacological research, ISSN 1043-6618, 08/2014, Volume 86, pp. 32 - 41
Indirect and direct mechanisms of action of PEA: entourage effect through competitive inhibition of AEA metabolism by FAAH... 
Pain | Acylethanolamide | Peroxisome proliferator-activated receptor | Food intake | Neurodegenerative disease | Inflammation | Behavior | Peroxisome proliferator-Activated receptor | N-PALMITOYLETHANOLAMIDE | PPAR-ALPHA | MAST-CELL ACTIVATION | MICROGLIAL ACTIVATION | ENDOCANNABINOID SYSTEM | SPINAL-CORD | PROLIFERATOR-ACTIVATED-RECEPTOR | ANTICONVULSANT ACTIVITY | FATTY-ACID AMIDE | REDUCES HYPERALGESIA | PHARMACOLOGY & PHARMACY | Neuroprotective Agents - therapeutic use | Ethanolamines - pharmacology | Neuroprotective Agents - immunology | Central Nervous System - metabolism | Humans | Palmitic Acids - therapeutic use | Anti-Inflammatory Agents - immunology | Ethanolamines - immunology | Pain - immunology | Neurodegenerative Diseases - drug therapy | Neurodegenerative Diseases - immunology | Pain - metabolism | Anti-Inflammatory Agents - metabolism | Central Nervous System - immunology | Neuroprotective Agents - metabolism | Inflammation - metabolism | Neuroprotective Agents - pharmacology | Inflammation - drug therapy | Pain - drug therapy | Palmitic Acids - immunology | Anti-Inflammatory Agents - therapeutic use | Palmitic Acids - pharmacology | PPAR alpha - immunology | Anti-Inflammatory Agents - pharmacology | Inflammation - immunology | Neurodegenerative Diseases - metabolism | Animals | Ethanolamines - metabolism | Central Nervous System - drug effects | Ethanolamines - therapeutic use | PPAR alpha - metabolism | Palmitic Acids - metabolism
Journal Article
Mini reviews in medicinal chemistry, ISSN 1389-5575, 04/2008, Volume 8, Issue 4, pp. 399 - 420
Journal Article
Neurobiology of aging, ISSN 0197-4580, 2009, Volume 30, Issue 10, pp. 1523 - 1534
Journal Article
Journal Article
British journal of pharmacology, ISSN 0007-1188, 2013, Volume 169, Issue 4, pp. 772 - 783
N-3 long chain polyunsaturated fatty acids (n-3 LC PUFAs), in particular a-linolenic acid (18:3n-3), eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic... 
in-vivo | n-3 | acylethanolamines | cannabinoid-receptor | cardiovascular-disease | amide hydrolase | rat-brain | cancer cell-lines | anandamide | arachidonoyl-serotonin | PUFA, DHA, EPA | endocannabinoid system | n‐3 | fish oil | Endocannabinoids - metabolism | Ethanolamine - therapeutic use | Neuroprotective Agents - therapeutic use | Cannabinoid Receptor Agonists - metabolism | Polyunsaturated Alkamides - chemistry | Eicosapentaenoic Acid - analogs & derivatives | Humans | Fatty Acids, Omega-3 - chemistry | Polyunsaturated Alkamides - therapeutic use | alpha-Linolenic Acid - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Cannabinoid Receptor Agonists - chemistry | Neuroprotective Agents - metabolism | Drug Delivery Systems | Receptors, Cannabinoid - metabolism | Ethanolamine - chemistry | Cannabinoid Receptor Agonists - therapeutic use | Fishes | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Dopamine - metabolism | Endocannabinoids - therapeutic use | Receptors, Cannabinoid - chemistry | Acylation | Docosahexaenoic Acids - therapeutic use | Dopamine - therapeutic use | Fatty Acids, Omega-3 - metabolism | Neuroprotective Agents - chemistry | alpha-Linolenic Acid - analogs & derivatives | Ethanolamine - metabolism | Eicosapentaenoic Acid - metabolism | Polyunsaturated Alkamides - metabolism | Docosahexaenoic Acids - analogs & derivatives | Animals | Dopamine - analogs & derivatives | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | alpha-Linolenic Acid - metabolism | Fatty Acids, Omega-3 - therapeutic use | Eicosapentaenoic Acid - therapeutic use | Seafood - analysis | Dietary Supplements | Fish Oils - chemistry | Endocannabinoids - chemistry | Docosahexaenoic Acids - metabolism | Ethanolamines | Omega-3 fatty acids | Linolenic acids | Fatty acids | Dopamine | Cannabinoids 2012, Part Two | Themed Section
Journal Article
Brain research, ISSN 0006-8993, 2016, Volume 1648, Issue Pt A, pp. 69 - 80
Journal Article
European journal of medicinal chemistry, ISSN 0223-5234, 2016, Volume 122, pp. 326 - 338
Journal Article